<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Goal blood pressure thresholds from different society guidelines according to underlying comorbidity</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Goal blood pressure thresholds from different society guidelines according to underlying comorbidity</h1>
<div class="graphic"><div class="figure"><div class="ttl">Goal blood pressure thresholds from different society guidelines according to underlying comorbidity</div><div class="cntnt"><table cellspacing="0"><colgroup width="19%"></colgroup><colgroup span="9" width="9%"></colgroup> <tbody> <tr> <td class="subtitle1">Underlying comorbidity</td> <td class="subtitle1"><span class="nowrap_whitespace">ACC/AHA<sup>[1]</sup></span></td> <td class="subtitle1"><span class="nowrap_whitespace">ESC/ESH<sup>[2]</sup></span></td> <td class="subtitle1"><span class="nowrap_whitespace">CHEP<sup>[3]</sup></span></td> <td class="subtitle1"><span class="nowrap_whitespace">NHFA<sup>[4]</sup></span></td> <td class="subtitle1"><span class="nowrap_whitespace">JHS<sup>[5]</sup></span></td> <td class="subtitle1"><span class="nowrap_whitespace">NICE<sup>[6]</sup></span></td> <td class="subtitle1"><span class="nowrap_whitespace">ACP/AAFP<sup>[7]</sup></span></td> <td class="subtitle1"><span class="nowrap_whitespace">ADA<sup>[8]</sup></span></td> <td class="subtitle1"><span class="nowrap_whitespace">KDIGO<sup>[9]</sup></span></td> </tr> <tr> <td>Established atherosclerotic cardiovascular <span class="nowrap_whitespace">disease<sup>*</sup></span></td> <td class="centered">&lt;130/80</td> <td class="centered">&lt;130/80</td> <td class="centered">&lt;120/80</td> <td class="centered">&lt;120/80</td> <td class="centered">&lt;130/80</td> <td class="centered">&lt;140/90</td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> </tr> <tr> <td>Heart failure</td> <td class="centered">&lt;130/80</td> <td class="centered">&lt;130/80</td> <td class="centered">&lt;120/80</td> <td class="centered">&lt;120/80</td> <td class="centered">&lt;130/80</td> <td class="centered">&lt;140/90</td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> </tr> <tr> <td>Diabetes mellitus</td> <td class="centered">&lt;130/80</td> <td class="centered">&lt;130/80</td> <td class="centered">&lt;130/80</td> <td class="centered">&lt;120/80</td> <td class="centered">&lt;130/80</td> <td class="centered">&lt;140/90</td> <td class="centered"> </td> <td class="centered"><span class="nowrap_whitespace">&lt;140/90<sup>¶</sup></span></td> <td class="centered"> </td> </tr> <tr> <td>Chronic kidney disease</td> <td class="centered">&lt;130/80</td> <td class="centered">&lt;130/80</td> <td class="centered">&lt;120/80</td> <td class="centered">&lt;120/80</td> <td class="centered">&lt;130/80</td> <td class="centered">&lt;140/90</td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered">&lt;120/80</td> </tr> <tr> <td>High cardiovascular <span class="nowrap_whitespace">risk<sup>Δ</sup></span></td> <td class="centered">&lt;130/80</td> <td class="centered">&lt;130/80</td> <td class="centered">&lt;120/80</td> <td class="centered">&lt;120/80</td> <td class="centered">&lt;130/80</td> <td class="centered">&lt;140/90</td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> </tr> <tr> <td>Older <span class="nowrap_whitespace">adults<sup>◊</sup></span></td> <td class="centered">&lt;130/80</td> <td class="centered">&lt;140/80</td> <td class="centered">&lt;120/80</td> <td class="centered">&lt;120/80</td> <td class="centered">&lt;140/90</td> <td class="centered">&lt;140/90</td> <td class="centered"><span class="nowrap_whitespace">&lt;150/90<sup>§</sup></span></td> <td class="centered"> </td> <td class="centered"> </td> </tr> <tr> <td>No comorbidity</td> <td class="centered">&lt;130/80</td> <td class="centered">&lt;130/80</td> <td class="centered">&lt;140/90</td> <td class="centered">&lt;140/90</td> <td class="centered">&lt;130/80</td> <td class="centered">&lt;140/90</td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> </tr> </tbody></table></div><div class="graphic_lgnd"><p>All targets listed are predicated on therapy being well tolerated. (In general, if a patient cannot tolerate the target blood pressure, then the target must be adjusted upward.)</p>
All values are in mmHg. All targets assume that blood pressure is monitored optimally (eg, with standardized office measurement, automated oscillometric blood pressure monitoring).</div><div class="graphic_footnotes"><p>ACC/AHA: American College of Cardiology/American Heart Association; ACP/AAFP: American College of Physicians/American Academy of Family Physicians; ADA: American Diabetes Association; CHEP: Canadian Hypertension Education Program; ESC/ESH: European Society of Cardiology/European Society of Hypertension; JHS: Japanese Hypertension Society; KDIGO: Kidney Disease Improving Global Outcomes; MI: myocardial infarction; NHFA: National Heart Foundation of Australia; NICE: National Institute for Health and Care Excellence (United Kingdom).</p>
<p>* Established atherosclerotic cardiovascular disease includes patients with prior MI, stroke, and peripheral artery disease.</p>
<p>¶ ADA suggests a lower target (&lt;130/80) mmHg in patients with diabetes at high cardiovascular risk.</p>
<p>Δ Defined as an elevated calculated 10-year risk of having an atherosclerotic cardiovascular event; "elevated" in this context often means ≥10 or ≥15% 10-year risk.</p>
<p>◊ CHEP and JHS define older adults as ≥75 years, ACP/AAFP defines older adults as ≥60 years, and other societies define older adults as ≥65 years.</p>
§ ACP/AAFP suggests a target of &lt;140/90 mmHg in older adults with high cardiovascular risk.</div><div class="graphic_reference">References:
<ol>
<li>Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018; 71:e13.</li>
<li>Mancia G, Kreutz R, Brunström, et al. 2023 ESH Guidelines for the management of arterial hypertension the Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens 2023; 41:1874.</li>
<li>Nerenberg KA, Zarnke KB, Leung AA, et al. Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. Can J Cardiol 2018; 34:506.</li>
<li>Gabb GM, Mangoni AA, Anderson CS, et al. Guideline for the diagnosis and management of hypertension in adults - 2016. Med J Aust 2016; 205:85.</li>
<li>Umemura S, Arima H, Arima S, Asayama K, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019). Hypertension Res 2019; 42:1235.</li>
<li>Hypertension in adults: Diagnosis and management. National Institute for Health and Care Excellence (NICE). Available at <a href="http://www.nice.org.uk/guidance/ng136" target="_blank">http://www.nice.org.uk/guidance/ng136</a> (Accessed April 19, 2021).</li>
<li>Qaseem A, Wilt TJ, Rich R, et al. Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med 2017; 166:430.</li>
<li>American Diabetes Association. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2021. Diabetes Care 2021; 44:S125.</li>
<li>Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int 2021; 99:S1.</li>
</ol></div><div id="graphicVersion">Graphic 131587 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
